Our history
Our experience and expertise date back more than 60 years. Discover our history
Minakem is a brand of Minafin
Latest news
Minafin Group appoints Olivier Ubrich as CEO of Health Chemistry Division
Louvain-la-Neuve, Belgium – September 5th, 2024 – The Minafin Group, a leading developer and producer of fine chemicals, today announced the appointment of Olivier Ubrich as CEO of its Health … Learn More
The EDQM has validated the updated CEP of Vinorelbine of Minakem, sole manufacturer in Europe
Louvain-la-Neuve, June 19th, 2024 – Vinorelbine is an important drug substance used to treat breast and lung cancers. Minakem is the sole API manufacturer located in Europe. This molecule remains … Learn More
Reshoring: Minakem Canada is manufacturing steroid APIs in a brand-new production unit
Minakem’s investment in a new production unit in Lassalle, Montreal, for corticosteroid APIs reflects the company’s recognition of the importance and growing demand for these active pharmaceutical ingredients (API). The … Learn More
The ‘Made in Canada’ label for API manufacturing is garnering increasing interest in the pharmaceutical industry
Montreal, April 8th, 2024 – The COVID-19 pandemic has prompted North America and Europe to reconsider the feasibility of slightly rebalancing their supply chains, which currently heavily rely on Asia. … Learn More
Upcoming events
DCAT Week
You are welcome to meet our APIs generics sales team to exchange about your new DP projects requiring an API or to evaluate opportunity to qualify Schedule a meeting
Minakem @ CPhI Japan
Minakem will be present at CPHI Japan to exchange on your API / HAPI supply request. For meeting us, please contact : contact@minakem.com If Schedule a meeting
Europlx Lisbon 2025
You are welcome to meet our APIs generics sales team to exchange about your new DP projects requiring an API or to evaluate opportunity to qualify Schedule a meeting
Key Figures
-
550Employees
-
35Export countries
-
3Production centers
-
40Scientists
-
107QA/QC Experts
-
290m³capacity
